Showing results (1761-1770 of 1,803) with videos related to
Sort By:
Pageof 181
Neurology|April 28, 2004
Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyJ A French, A M Kanner, J Bautista, et al.Blood|June 27, 2012
Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemiaRobert E Gallagher, Barry K Moser, Janis Racevskis, et al.Cell|September 10, 2019
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial DependenceMichal Harel, Rona Ortenberg, Siva Karthik Varanasi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2022
Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomasG Ghilardi, E A Chong, J Svoboda, et al.Neurology|April 28, 2004
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyJ A French, A M Kanner, J Bautista, et al.The New England Journal of Medicine|June 6, 2019
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic MelanomaCaroline Robert, Jean J Grob, Daniil Stroyakovskiy, et al.The Journal of Infectious Diseases|February 25, 2012
Multicohort genomewide association study reveals a new signal of protection against HIV-1 acquisitionSophie Limou, Olivier Delaneau, Daniëlle van Manen, et al.Epilepsia|April 23, 2004
Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy SocietyJacqueline A French, Andres M Kanner, Jocelyn Bautista, et al.The Review of Scientific Instruments|March 5, 2008
A status report of the multipurpose superconducting electron cyclotron resonance ion sourceG Ciavola, S Gammino, S Barbarino, et al.Oncoimmunology|July 4, 2012
TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patientsPia Kvistborg, Chengyi Jenny Shu, Bianca Heemskerk, et al.Pageof 181